一期抗生素涂层模制髋关节间隔器植入后的临床结局
该回顾性研究纳入2009-2019年间在某三级转诊中心植入特定模制关节型抗生素髋关节间隔器的88例假体周围感染患者,平均随访4.2年。38.6%患者完成清洁二期流程并成功再植入且1年无感染证据,总体再植入率72%,机械并发症发生率较高,既往行延长大转子截骨者并发症更多且感染清除率更低。
要点
- 88例患者中34例(38.6%)完成清洁二期流程,再植入后1年无感染证据
- 总体再植入率72%,其余61.4%患者需额外手术3.67(±0.52)次
- 既往延长大转子截骨者间隔器柄弯曲/断裂、假体周围骨折、脱位率更高且感染清除率更低
核心结论
- 在该三级转诊中心植入特定模制关节型髋关节间隔器的患者中,感染根除率与已发表的髋关节假体周围感染治疗系列大致相当。
- 机械并发症发生率较高,尤其是在需要延长大转子截骨的患者中。
研究设计与样本
- 回顾性查询机构数据库,纳入2009-2019年间接受间隔器植入的患者。
- 共纳入88例患者,平均年龄60.4岁,平均随访4.2年(标准差2.5年)。
主要发现
- 34例(38.6%)患者完成清洁二期流程,成功再植入且1年随访无感染证据;其余患者(61.4%)需额外手术3.67(±0.52)次。
- 总体再植入率为72%。
- 致病菌包括MSSA(n=22)、MRSA(n=16)、凝固酶阴性葡萄球菌(n=14)和多种微生物混合感染(n=12)。
- 并发症包括脱位13例(15%)、假体周围骨折16例(18%)、间隔器柄弯曲/断裂8例(9%)、临床显著下沉16例(18%)。
- 既往延长大转子截骨患者与无此病史者相比:间隔器柄弯曲/断裂率25% vs 3.1%(P=0.006),假体周围骨折率37.5% vs 10.9%(P=0.010),脱位率37.5% vs 6.2%(P=0.001),感染清除率26.6% vs 54.2%(P=0.029)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Two-stage exchange remains the gold standard for managing periprosthetic joint infection (PJI). We evaluated the outcomes of patients treated with a specific molded articulating antibiotic hip spacer for PJI at a tertiary referral center. METHODS: An institutional database was retrospectively queried for patients who underwent implantation of spacer between 2009-2019. Patient demographics and clinical outcomes were collected. RESULTS: We identified 88 patients at an average age of 60.4 years who received a spacer implant, with an average of 4.2 years follow-up (standard deviation [SD] 2.5 years). A total of 34 patients (38.6%) had a "clean" two-stage course with successful reimplantation and no evidence of infection at 1-year follow-up. The remaining patients (61.4%) required 3.67 (±0.52) additional surgeries. Overall reimplantation rate was 72%. Causative bacterial agents included MSSA (n = 22), MRSA (n = 16), coagulase-negative Staphylococcus (n = 14), and polymicrobial (n = 12). Regarding complications, there were 13 (15%) dislocations, 16 (18%) periprosthetic fractures, 8 (9%) bent/fractured stems, and 16 (18%) patients had clinically significant subsidence. Patients with previous extended trochanteric osteotomy (ETO) experienced higher rates of bent/broken spacer stems (25% vs 3.1%; P = .006) periprosthetic fractures (37.5% vs 10.9%; P = .010), and dislocations (37.5% vs 6.2%; P = .001). The rate of infection clearance was lower in the prior ETO cohort (26.6% vs 54.2%; P = .029). CONCLUSION: We report outcomes in patients who underwent implantation of a specific molded articulating hip spacer at our institution. Infection eradication was roughly in line with published series of hip PJI treatment. There was a high rate of mechanical complications, especially in those patients who required an ETO.
引用
- Duensing IM, Kim BI, Charalambous LT, et al. Clinical Outcomes After Stage-One Antibiotic Coated Molded Hip Spacer. J Arthroplasty. 2022. PMID: 35259464. doi:10.1016/j.arth.2022.02.116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。